Library Catalog

Syndetics cover image
Image from Syndetics

U.S. markets for vaccines : characteristics, case studies, and controversies / Ernst R. Berndt, Rena N. Denoncourt, and Anjli C. Warner.

By: Berndt, Ernst R.
Contributor(s): Denoncourt, Rena N | Warner, Anjli C.
Material type: TextTextPublisher: Washington, D.C. : Blue Ridge Summit, PA : AEI Press ; Distributed to the trade by National Book Network, 2009Bibliography: Includes bibliographical references (p. 205-226) and index.Description: xi, 236 p. : ill. ; 23 cm.ISBN: 9780844742809; 0844742805.Subject(s): Vaccines industry -- United States | Market surveys -- United States | Pharmaceutical industry -- Economic aspects | Pharmaceutical industry -- Technological innovations | Drugs -- ResearchDDC classification: 381/.456153720973 Online resources: Table of contents
Contents:
Envisaging and developing a vaccine -- Planning for vaccine launch -- Rolling out the new vaccine -- Diphtheria, tetanus, and pertussis and related combination vaccines -- Seasonal influenza vaccines -- Prevnar : the seven-valent pneumococcal conjugate vaccine -- Varicella zoster vaccines -- Challenges in maintaining public trust in vaccine safety -- Beyond the turning point: the expanding focus of vaccine R&D.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Status Date due Barcode
Two Weeks Davenport Library Circulating Collection Print-Circulating 381.45615372 B457 2009 (Browse shelf(Opens below)) Available 34284003711355

Includes bibliographical references (p. 205-226) and index.

Envisaging and developing a vaccine -- Planning for vaccine launch -- Rolling out the new vaccine -- Diphtheria, tetanus, and pertussis and related combination vaccines -- Seasonal influenza vaccines -- Prevnar : the seven-valent pneumococcal conjugate vaccine -- Varicella zoster vaccines -- Challenges in maintaining public trust in vaccine safety -- Beyond the turning point: the expanding focus of vaccine R&D.

There are no comments on this title.

to post a comment.

Powered by Koha